| 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 4,7 M € | +2.3% | 4,6 M € | +1.3% | 4,5 M € | — | — | — | — | — | — | — | |||||||||||||||
| Gross margin | 1,3 M € | -17.1% | 1,6 M € | +26.1% | 1,3 M € | -8.6% | 1,4 M € | +97.9% | 692,3 k € | -6.7% | 742,1 k € | -10.3% | 827,6 k € | — | — | — | 1,1 M € | +5.2% | 1,0 M € | -1.2% | 1,1 M € | +8.9% | 972,5 k € | -4.0% | 1,0 M € | +23.4% | 820,5 k € | -1.5% | 833,2 k € | |||||
| EBITDA | 620,3 k € | -20.0% | 775,1 k € | +45.1% | 534,0 k € | -20.8% | 674,3 k € | +556.3% | 102,7 k € | -44.9% | 186,3 k € | -13.3% | 214,8 k € | -55.4% | 481,8 k € | -16.6% | 578,0 k € | -7.5% | 624,7 k € | -0.1% | 625,6 k € | +36.3% | 459,0 k € | -8.4% | 501,0 k € | +15.9% | 432,3 k € | -12.4% | 493,3 k € | +36.6% | 361,1 k € | -15.1% | 425,1 k € | |
| Operating profit | 616,2 k € | -19.5% | 765,8 k € | +46.6% | 522,5 k € | -15.4% | 617,3 k € | +525.7% | 98,6 k € | -45.9% | 182,2 k € | -14.6% | 213,2 k € | -51.7% | 441,6 k € | -23.6% | 578,1 k € | -6.6% | 619,3 k € | -1.0% | 625,3 k € | +36.3% | 458,7 k € | -8.4% | 501,0 k € | +15.9% | 432,3 k € | -12.4% | 493,3 k € | +36.6% | 361,1 k € | -15.1% | 425,1 k € | |
| Profit/loss | 444,6 k € | -20.3% | 558,0 k € | +47.8% | 377,5 k € | -16.0% | 449,4 k € | +606.8% | 63,6 k € | -40.5% | 106,8 k € | -16.1% | 127,2 k € | -56.0% | 289,0 k € | -25.6% | 388,3 k € | -7.6% | 420,4 k € | -0.2% | 421,1 k € | +37.4% | 306,4 k € | -6.9% | 329,1 k € | +9.3% | 301,1 k € | -16.9% | 362,3 k € | +38.0% | 262,5 k € | -1.8% | 267,2 k € | |
| Equity | 1,6 M € | -40.2% | 2,6 M € | +27.0% | 2,1 M € | +22.4% | 1,7 M € | +62.5% | 1,0 M € | +6.5% | 974,6 k € | +12.3% | 867,8 k € | -73.2% | 3,2 M € | +9.8% | 3,0 M € | +15.6% | 2,6 M € | +19.7% | 2,1 M € | +24.6% | 1,7 M € | +21.8% | 1,4 M € | +30.6% | 1,1 M € | +38.8% | 775,2 k € | -45.1% | 1,4 M € | +22.8% | 1,2 M € | |
| Total assets | 2,1 M € | -30.9% | 3,0 M € | +15.9% | 2,6 M € | +27.9% | 2,0 M € | +36.8% | 1,5 M € | -5.7% | 1,6 M € | -23.9% | 2,1 M € | -46.8% | 3,9 M € | +12.4% | 3,5 M € | +20.4% | 2,9 M € | +16.2% | 2,5 M € | +28.7% | 1,9 M € | +18.8% | 1,6 M € | +15.0% | 1,4 M € | +16.3% | 1,2 M € | -37.6% | 2,0 M € | +26.9% | 1,5 M € | |
| Cash | 977,8 k € | -33.0% | 1,5 M € | -2.2% | 1,5 M € | +39.1% | 1,1 M € | +69.6% | 631,9 k € | +90.0% | 332,5 k € | -64.1% | 925,8 k € | -67.8% | 2,9 M € | +14.5% | 2,5 M € | +36.0% | 1,8 M € | +27.3% | 1,5 M € | +59.6% | 909,2 k € | +56.7% | 580,2 k € | +13.6% | 510,9 k € | +72.1% | 296,9 k € | -67.2% | 905,5 k € | +15.9% | 781,2 k € | |
| Debts | 531,0 k € | +28.0% | 415,0 k € | -25.3% | 555,9 k € | +53.9% | 361,2 k € | -21.0% | 457,0 k € | -25.4% | 612,5 k € | -49.7% | 1,2 M € | +79.8% | 677,7 k € | +26.8% | 534,4 k € | +56.3% | 341,8 k € | -4.5% | 358,0 k € | +59.7% | 224,2 k € | -0.3% | 224,8 k € | -34.2% | 341,6 k € | -23.1% | 444,2 k € | -18.0% | 541,7 k € | +39.0% | 389,7 k € | |
| Staff | 6,8 | 7,7 | 7,3 | 6,5 | 7,5 | 7,6 | 6,9 | 6,7 | 5,5 | 5,9 | 6,3 | 7,5 | 7,5 | 7,5 | 7,1 | 7,2 | 6,2 | |||||||||||||||||
Private limited company · Antwerpen · incorporated on 08/07/1976 · 6,8 ETP
Private limited company profitable and well capitalised. Cash position declining (-33.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Sarstedt is a Private limited company incorporated in 1976. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Antwerpen. It employs on average 6,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette